Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptide Receptor Radionuclide Therapy
Johannes Hofland, Tessa Brabander, Frederik A. Verburg, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 12, pp. 3199-3208
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Cancer treatments: Past, present, and future
Dmitriy Sonkin, Anish Thomas, Beverly A. Teicher
Cancer Genetics (2024) Vol. 286-287, pp. 18-24
Open Access | Times Cited: 111
Approach to the Patient: Insulinoma
Johannes Hofland, Julie Refardt, Richard A. Feelders, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 4, pp. 1109-1118
Open Access | Times Cited: 25
Cysteine‐Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5‐Substituted 1,2,3‐Triazines
Quan Zuo, Yiping Li, Xuanliang Lai, et al.
Advanced Science (2024) Vol. 11, Iss. 21
Open Access | Times Cited: 12
Aggressive Pituitary Tumors and Pituitary Carcinomas: definition, management and overview for clinical practice
Francesco Calvanese, Gianpaolo Jannelli, L. Feuvret, et al.
Neuro-Oncology Advances (2025)
Open Access | Times Cited: 1
Radiolysis-Associated Decrease in Radiochemical Purity of 177Lu-Radiopharmaceuticals and Comparison of the Effectiveness of Selected Quenchers against This Process
А. А. Ларенков, Yu. A. Mitrofanov, Ekaterina Pavlenko, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1884-1884
Open Access | Times Cited: 18
RYZ101 (Ac-225 DOTATATE) Opportunity beyond Gastroenteropancreatic Neuroendocrine Tumors: Preclinical Efficacy in Small-Cell Lung Cancer
Guangzhou Han, Eunmi Hwang, Fanching Lin, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 12, pp. 1434-1443
Open Access | Times Cited: 11
Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy
Cyprine Neba Funeh, Jessica Bridoux, Thomas Ertveldt, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1378-1378
Open Access | Times Cited: 10
Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy
Turgut Bora Cengiz, Raksha Kulkarni, Virginia Corbett, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Pancreatic Neuroendocrine Tumors—Diagnostic Pitfalls of Non-Diabetic Severe Hypoglycemia: Literature Review and Case Report
Simona Georgiana Popa, Andreea Loredana Golli, Cristina Matei, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 337-337
Open Access
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global Initiative
Akram Al‐Ibraheem, Andrew M. Scott, Ahmed Saad Abdlkadir, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.269215-jnumed.124.269215
Closed Access
Gastrointestinal neuroendocrine tumor syndromes (GI-NETS)
Tetsuhide Ito, Robert T. Jensen
Elsevier eBooks (2025)
Closed Access
The Effects of Peptide Receptor Radionuclide Therapy on the Neoplastic and Normal Pituitary
Pedro Marques
Cancers (2023) Vol. 15, Iss. 10, pp. 2710-2710
Open Access | Times Cited: 9
Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma
Chan Kwon Jung, Shipra Agarwal, Jen‐Fan Hang, et al.
Endocrine Pathology (2023) Vol. 34, Iss. 1, pp. 1-22
Closed Access | Times Cited: 8
Anatomy-based correction of kidney PVE on $$^{177}\text{Lu}$$ SPECT images
Julien Salvadori, O. Allegrini, Thomas Opsommer, et al.
EJNMMI Physics (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Advancements in therapeutic peptides: Shaping the future of cancer treatment
Xiaojie Chen, Zhiwei Zhao, Kyle Vaughn Laster, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189197-189197
Closed Access | Times Cited: 2
Non-Interventional Management of Advanced Pancreatic Neuroendocrine Neoplasms in Patients with von Hippel-Lindau Disease
Reut Halperin, Amit Tirosh
Cancers (2023) Vol. 15, Iss. 6, pp. 1739-1739
Open Access | Times Cited: 6
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities
Alessio Impériale, Valentina Berti, Mickaël Burgy, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 25, Iss. 1, pp. 187-202
Closed Access | Times Cited: 5
Renal Disturbances during and after Radioligand Therapy of Neuroendocrine Tumors—Extended Analysis of Potential Acute and Chronic Complications
Marek Saracyn, Adam Daniel Durma, Barbara Bober, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7508-7508
Open Access | Times Cited: 4
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways
Simona Serioli, Ludovico Agostini, Alberto Pietrantoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15719-15719
Open Access | Times Cited: 4
Cancer Treatments: Past, Present, and Future
Dmitriy Sonkin, Anish Thomas, Beverly A. Teicher
(2024)
Open Access | Times Cited: 1
Current and preclinical treatment options for Merkel cell carcinoma
Büke Celikdemir, Roland Houben, Thibault Kervarrec, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 10, pp. 1015-1034
Open Access | Times Cited: 3
PET/CT with various radiopharmaceuticals in the complex diagnosis of medullary thyroid carcinoma: a review
N. V. Tsentr, A. E. Ertman, Д. В. Рыжкова
Diagnostic radiology and radiotherapy (2023) Vol. 14, Iss. 2, pp. 31-41
Open Access | Times Cited: 1
Pancreatic neuroendocrine tumors: classification, diagnosis and treatment – A review of the most frequent neuroendocrine tumors
Dominika Karolina Adamiec, Marta Justyna Gonciarz, Anna Dąbrowska, et al.
Quality in Sport (2024) Vol. 19, pp. 53611-53611
Open Access
Cardiac Surgery and Transcatheter Intervention for Valvular Heart Disease in Carcinoid Syndrome: Risk Factors, Outcomes, and Evolving Therapeutic Strategies
Mariagrazia Piscione, Valeria Cammalleri, Giorgio Antonelli, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 11, pp. 359-359
Open Access
The Value of Repeat 5-HIAA Measurements as a Predictor of Carcinoid Heart Disease: A Prospective 5-Year Follow-Up Study in Patients with Small Intestinal Neuroendocrine Tumors
Iiro Kostiainen, Piia Simonen, Katri Aaltonen, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3896-3896
Open Access
Page 1 - Next Page

Scroll to top